Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis.

Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, Ali MK.

PLoS Med. 2016 Jul 26;13(7):e1002095. doi: 10.1371/journal.pmed.1002095. eCollection 2016 Jul.

2.

Cost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program.

Hollenbeak CS, Weinstock RS, Cibula D, Delahanty LM, Trief PM.

Health Serv Insights. 2016 Jul 6;9:21-8. doi: 10.4137/HSI.S39084. eCollection 2016.

3.

Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts.

Mamtani M, Kulkarni H, Wong G, Weir JM, Barlow CK, Dyer TD, Almasy L, Mahaney MC, Comuzzie AG, Glahn DC, Magliano DJ, Zimmet P, Shaw J, Williams-Blangero S, Duggirala R, Blangero J, Meikle PJ, Curran JE.

Lipids Health Dis. 2016 Apr 4;15:67. doi: 10.1186/s12944-016-0234-3.

4.

Cost-effectiveness of the LIFE Physical Activity Intervention for Older Adults at Increased Risk for Mobility Disability.

Groessl EJ, Kaplan RM, Castro Sweet CM, Church T, Espeland MA, Gill TM, Glynn NW, King AC, Kritchevsky S, Manini T, McDermott MM, Reid KF, Rushing J, Pahor M; LIFE Study Group.

J Gerontol A Biol Sci Med Sci. 2016 May;71(5):656-62. doi: 10.1093/gerona/glw001. Epub 2016 Feb 17.

PMID:
26888433
5.

Treatment of prediabetes.

Kanat M, DeFronzo RA, Abdul-Ghani MA.

World J Diabetes. 2015 Sep 25;6(12):1207-22. doi: 10.4239/wjd.v6.i12.1207. Review.

6.

Medication costs during an 18 month clinical trial of obesity treatment among patients encountered in primary care.

Tsai AG, Juarez-Colunga E, Felton S, Speer RB, Bessesen DH, Atherly AJ.

BMC Obes. 2015 May 29;2:24. doi: 10.1186/s40608-015-0054-4. eCollection 2015.

7.

Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.

Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, Hopkins D, Pronk NP.

Ann Intern Med. 2015 Sep 15;163(6):452-60. doi: 10.7326/M15-0469. Review.

8.

An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications.

Meenan RT, Stumbo SP, Yarborough MT, Leo MC, Yarborough BJ, Green CA.

Adm Policy Ment Health. 2016 Jul;43(4):604-15. doi: 10.1007/s10488-015-0669-2.

PMID:
26149243
9.

Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial.

Ma J, Yank V, Lv N, Goldhaber-Fiebert JD, Lewis MA, Kramer MK, Snowden MB, Rosas LG, Xiao L, Blonstein AC.

Contemp Clin Trials. 2015 Jul;43:260-78. doi: 10.1016/j.cct.2015.06.010. Epub 2015 Jun 19.

10.

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.

Hostalek U, Gwilt M, Hildemann S.

Drugs. 2015 Jul;75(10):1071-94. doi: 10.1007/s40265-015-0416-8. Review.

11.
12.

Effective intervention of self-care on glycaemia control in patients with type 2 diabetes.

Zareban I, Niknami S, Hidarnia A, Rakhshani F, Shamsi M, Karimy M.

Iran Red Crescent Med J. 2014 Dec 18;16(12):e8311. doi: 10.5812/ircmj.8311. eCollection 2014 Dec.

PMID:
25763251
Free PMC Article
13.

The effect of self-care education program on reducing HbA1c levels in patients with type 2 diabetes.

Zareban I, Karimy M, Niknami S, Haidarnia A, Rakhshani F.

J Educ Health Promot. 2014 Nov 29;3:123. doi: 10.4103/2277-9531.145935. eCollection 2014.

14.

Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.

Png ME, Yoong JS.

PLoS One. 2014 Sep 9;9(9):e107225. doi: 10.1371/journal.pone.0107225. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0120831.

15.

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting.

Ofori SN, Unachukwu CN.

Diabetes Metab Syndr Obes. 2014 May 23;7:159-68. doi: 10.2147/DMSO.S62320. eCollection 2014. Review.

16.

Cost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose tolerance.

Ikeda S, Kobayashi M, Tajima N.

J Diabetes Investig. 2010 Dec 3;1(6):252-8. doi: 10.1111/j.2040-1124.2010.00052.x.

17.

Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence.

Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL; Diabetes Prevention Program Research Group.

Int J Behav Nutr Phys Act. 2014 Feb 12;11:16. doi: 10.1186/1479-5868-11-16.

18.

Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program.

Sathish T, Williams ED, Pasricha N, Absetz P, Lorgelly P, Wolfe R, Mathews E, Aziz Z, Thankappan KR, Zimmet P, Fisher E, Tapp R, Hollingsworth B, Mahal A, Shaw J, Jolley D, Daivadanam M, Oldenburg B.

BMC Public Health. 2013 Nov 4;13:1035. doi: 10.1186/1471-2458-13-1035.

19.
20.

Cost-effectiveness of a primary care intervention to treat obesity.

Tsai AG, Wadden TA, Volger S, Sarwer DB, Vetter M, Kumanyika S, Berkowitz RI, Diewald LK, Perez J, Lavenberg J, Panigrahi ER, Glick HA.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S31-7. doi: 10.1038/ijo.2013.94.

Items per page

Supplemental Content

Write to the Help Desk